Zydus Pharmaceuticals UK Ltd Awarded
Market Entrant Of The Year!
We are extremely pleased to announce that Zydus Pharmaceuticals UK Ltd has been honoured with an award from the India Global Forum as Market Entrant Of The Year at their 6th Annual Event on 27th June 2024!
This award recognizes our impactful entry into the UK pharmaceutical market through the strategic acquisition of LiqMeds Group and the rapid operational establishment of Zydus UK. Our commitment to bringing complex and innovative generics, manufactured in our state-of-the-art facilities, enhances access to crucial medications for UK patients
With a focus on innovation, Zydus Group are leveraging our extensive Research and Development capabilities to develop cutting-edge medicines and therapies, aiming to positively impact lives across the globe.
Our diverse portfolio covers a wide range of therapeutic areas, offering essential and affordable medicine with innovations in dosing, delivery forms and administration mechanisms etc. We are continuously seeking to apply technologies at the stage of formulation and manufacturing that ultimately increase efficiency in production, supply, and distribution of our medicines.
We look forward to furthering our investment in the UK, expanding operations, and creating job opportunities for skilled professionals, contributing to the growth and vitality of the UK economy.
Together, let's build a healthier future with Zydus Pharmaceuticals UK and Zydus Lifesciences.